Direct-to-consumer telehealth platform for chronic weight, hair, and hormone conditions
Voy operates a multi-category telehealth service launched in 2022 (originally as MANUAL) across the UK, Germany, and Brazil, now serving over 1 million members. The stack is heavily weighted toward CRM (NetSuite, Customer.io, Braze, Salesforce) and performance marketing (Meta, TikTok, Google Analytics), with no AI or automation tooling evident—a gap that matters given their stated pain points around slow campaign velocity, high customer acquisition cost, and conversion optimization. Hiring velocity is accelerating, concentrated in marketing and operations, suggesting they're scaling revenue operations and campaign execution alongside product expansion into hair loss, testosterone, and menopause.
Voy is a direct-to-consumer telehealth company offering managed care programs for weight loss, hair loss, testosterone, and menopause across the UK, Germany, and Brazil. The business model combines digital-first patient intake and monitoring with remote clinical oversight, supported by evidence-based coaching. Core operational challenges include clinical governance in regulated markets, managing customer acquisition cost at scale, and reducing support ticket volume. The platform runs on NetSuite for enterprise resource planning, Braze and Customer.io for patient communication, and Salesforce for customer relationship management, with a strong creative and design practice built in Figma and Adobe.
Voy operates in the United Kingdom, Germany, and Brazil, with current hiring activity in the UK and Brazil. The company is headquartered in London.
Core systems include NetSuite (ERP), Salesforce (CRM), Customer.io and Braze (customer engagement), Webflow and HTML/CSS (web), Figma (design), and Adobe Creative Suite (content production). Marketing leverages Meta Ads Manager, TikTok Ads Manager, and Google Analytics.
Voy supports over 1 million members worldwide across its health categories. The company was founded in 2022 and rebranded in 2025 to expand beyond weight loss into hair loss, testosterone, and menopause.
Other companies in the same industry, closest in size